Phase
Condition
Yeast Infections
Vaginal Infection
Fungal Infections
Treatment
N/AClinical Study ID
Ages 18-80 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with clinical symptoms and signs of vulvovaginal candidiasis.
- Patients tested positive for Candida by fungal culture.
- Patients who can agree not to have intercourse up to 28 days after dosing.
Exclusion
Exclusion Criteria:
- Patients with a history of hypersensitivity to fluconazole.
- Patients with severe renal dysfunction.
- Patients with liver disorder.
Study Design
Connect with a study center
Ai WOMEN'S CLINIC
Asahikawa, Hokkaido 070-8003
JapanSite Not Available
Seiko Ladies Clinic
Chuo-ku, Tokyo
JapanSite Not Available
Shirokane Ladies' Clinic
Minato-ku, Tokyo 108-0071
JapanSite Not Available
Takane Medical Clinic
Shinagawa-ku, Tokyo 140-0013
JapanSite Not Available
Suzuran Clinic
Suginami-ku, Tokyo 167-0051
JapanSite Not Available
Mori Ladies Clinic
Fukuoka, 810-0011
JapanSite Not Available
IZUMI Ladies' Clinic
Gifu, 502-0914
JapanSite Not Available
Tetsu-Nakamura Obstetrics and Gynecology Department Internal Medicine
Kagoshima, 892-0845
JapanSite Not Available
Women's Clinic Kamimura
Okayama, 700-0901
JapanSite Not Available
Hayakawa Clinic
Osaka, 542-0086
JapanSite Not Available
Sutou Ladies Clinic
Osaka, 542-0081
JapanSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.